We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Niox Group Plc | LSE:NIOX | London | Ordinary Share | GB00BJVD3B28 | ORD 0.08P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.40 | 0.57% | 70.60 | 70.00 | 71.80 | 70.20 | 70.20 | 70.20 | 687,679 | 16:35:20 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 33.3M | 16.1M | 0.0383 | 18.33 | 295.15M |
From Dec 2023 to Jun 2024
TIDMNIOX
RNS Number : 3490Y
Niox Group PLC
02 January 2024
NIOX Group plc
Total Voting Rights Update
2 January 2024
In accordance with the requirements of the FCA's Disclosure and Transparency Rule 5.6.1, NIOX Group plc (the "Company") (AIM: NIOX) confirms that, following the exercise of options over a total of 150,000 Ordinary Shares of 0.08p ("Ordinary Shares") by certain employees under the Company's share option schemes during the month, the Company's issued share capital consists of 420,907,123 Ordinary Shares in issue, each carrying one voting right. No shares are held in treasury.
Admission of the new Ordinary Shares issued during the month has in each case been satisfied via the block listing for the relevant option scheme.
The above figure of 420,907,123 shares may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules .
-Ends-
For further information, please contact: NIOX Group plc Sarah Duncan, Company Secretary +44 (0) 3303 309 356 Singer Capital Markets (Nominated Adviser & Broker) Aubrey Powell / Jen Boorer +44 (0) 20 7496 3000
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCBTMPTMTBMMPI
(END) Dow Jones Newswires
January 02, 2024 03:30 ET (08:30 GMT)
1 Year Niox Chart |
1 Month Niox Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
